Taipei Exchange - Delayed Quote TWD

TCM Biotech International Corp. (4169.TWO)

Compare
56.30
-0.20
(-0.35%)
At close: 2:59:23 PM GMT+8
Currency in TWD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
969,619.00
969,619.00
802,421.00
702,046.00
737,078.00
Cost of Revenue
489,451.00
489,451.00
353,933.00
343,328.00
368,154.00
Gross Profit
480,168.00
480,168.00
448,488.00
358,718.00
368,924.00
Operating Expense
457,839.00
457,839.00
422,702.00
356,587.00
331,122.00
Operating Income
22,329.00
22,329.00
25,786.00
2,131.00
37,802.00
Net Non Operating Interest Income Expense
-1,224.00
-1,224.00
-2,247.00
-1,930.00
-1,879.00
Pretax Income
22,032.00
22,032.00
23,125.00
2,257.00
36,134.00
Tax Provision
3,458.00
3,458.00
4,860.00
384.00
10,592.00
Net Income Common Stockholders
18,574.00
18,574.00
18,265.00
1,873.00
25,542.00
Diluted NI Available to Com Stockholders
18,574.00
18,574.00
18,265.00
1,873.00
25,542.00
Basic EPS
0.35
--
0.37
0.04
0.50
Diluted EPS
0.35
--
0.37
0.04
0.50
Basic Average Shares
53,021.00
--
49,049.00
50,736.32
50,484.93
Diluted Average Shares
53,049.00
--
49,106.00
50,739.55
50,528.98
Total Expenses
947,290.00
947,290.00
776,635.00
699,915.00
699,276.00
Net Income from Continuing & Discontinued Operation
18,574.00
18,574.00
18,265.00
1,873.00
25,542.00
Normalized Income
18,574.00
18,574.00
18,647.28
1,873.00
26,072.15
Interest Income
1,548.00
1,548.00
138.00
41.00
68.00
Interest Expense
2,772.00
2,772.00
2,385.00
1,971.00
1,947.00
Net Interest Income
-1,224.00
-1,224.00
-2,247.00
-1,930.00
-1,879.00
EBIT
24,804.00
24,804.00
25,510.00
4,228.00
38,081.00
EBITDA
46,699.00
46,699.00
45,513.00
22,280.00
53,150.00
Reconciled Cost of Revenue
489,451.00
489,451.00
353,933.00
343,328.00
368,154.00
Reconciled Depreciation
21,895.00
21,895.00
20,003.00
18,052.00
15,069.00
Net Income from Continuing Operation Net Minority Interest
18,574.00
18,574.00
18,265.00
1,873.00
25,542.00
Total Unusual Items Excluding Goodwill
--
--
-484.00
--
-750.00
Total Unusual Items
--
--
-484.00
--
-750.00
Normalized EBITDA
46,699.00
46,699.00
45,997.00
22,280.00
53,900.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
--
--
-101.72
--
-219.85
12/31/2020 - 6/20/2012

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

4170.TWO VBI
14.10
+0.71%
 
7754.TWO AnnJi
32.55
-3.70%
 
4197.TWO Visgeneer Inc.
9.78
0.00%
 
6744.TWO Feng Chi Biotech Corp.
19.70
0.00%
 
6652.TWO Eusol Biotech Co.,Ltd.
7.77
-0.38%
 
6748.TWO ACRO Biomedical Co., Ltd.
24.80
+1.02%
 
6827.TWO MegaPro Biomedical Co., Ltd
14.45
+2.48%
 
6580.TWO TaiRx, Inc.
26.00
+1.96%
 
6549.TWO TaiwanJ Pharmaceuticals Co., Ltd.
7.98
-2.80%
 
4195.TWO Genomics BioSci & Tech. Co.,Ltd.
18.90
+2.16%